CNS Pharmaceuticals, Inc. (CNSP) — Total Assets
| Fiscal Year | Total Assets | Change YoY |
|---|---|---|
| 2025 | $8.62M | -0.9% |
| 2024 | $8.70M | +411.6% |
| 2023 | $1.70M | -87.0% |
| 2022 | $13.05M | +49.1% |
| 2021 | $8.76M | -44.8% |
| 2020 | $15.85M | +100.4% |
| 2019 | $7.91M | +1057.9% |
| 2018 | $683.3K | — |
| Fiscal Year | Total Assets | Change YoY |
|---|---|---|
| 2025 | $8.62M | -0.9% |
| 2024 | $8.70M | +411.6% |
| 2023 | $1.70M | -87.0% |
| 2022 | $13.05M | +49.1% |
| 2021 | $8.76M | -44.8% |
| 2020 | $15.85M | +100.4% |
| 2019 | $7.91M | +1057.9% |
| 2018 | $683.3K | — |